San Francisco, CA, United States of America

Napoleone Ferrara

This inventor holds 106 USPTO granted patents and 29 published patent applications, plus 5 CIPO patents and 20 EPO patents, primarily in VEGF Inhibitors (CPC class 4353201). Top assignees: Genentech, Inc., University of California, Genetech, Inc.. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Napoleone Ferrara. Retrieved from https://idiyas.com/inventor/napoleone-ferrara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 106 (Patent Applications = 29)

% Patents Active = 58.5

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 20 (Patent Applications = 22)

Average Co-Inventor Count = 3.6

ph-index = 19

Forward Citations = 1,495(Granted Patents)

Forward Citations (Not Self Cited) = 1,372(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Belvedere, CA (US) (1994 - 2005)
South San Francisco, CA (US) (2014)
San Francisco, CA (US) (1996 - 2016)
La Jolla, CA (US) (2016 - 2022)
San Diego, CA (US) (2022 - 2023)

Company Filing History:

University of California

F. Hoffmann-La Roche Ag

patents

5. 1 out of 11

St. Elizabeth's Medical Center of Boston, Inc.

patents

where one patent can have more than one assignee

Years Active: 1994-2026

Loading Chart...

Areas of Expertise:

VEGF Inhibitors

Anti-VEGF Agents

Angiogenic Disorders

Hematopoietic Activity

Vascular Endothelial Growth Factor

Anti-BV8 Antibodies

Angiopoietin-like Proteins

Transgenic Mice

Humanized Antibodies

Nucleic Acids

Polypeptides

Liver Protection

106 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514905 - Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents (2026-01-06),

2. 12514904 - LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION (2026-01-06),

3. 11576948 - Long-acting VEGF inhibitors for intraocular neovascularization (2023-02-14),

4. 11524053 - Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents (2022-12-13),

5. 11433118 - Long-acting VEGF inhibitors for intraocular neovascularization (2022-09-06),

6. 11382955 - Long-acting VEGF inhibitors for intraocular neovascularization (2022-07-12),

7. 9273113 - Methods of inhibiting vascular endothelial growth factor activity (2016-03-01),

8. 9266948 - Anti-Bv8 antibodies and uses thereof (2016-02-23),

9. 8858936 - Compositions with hematopoietic and immune activity (2014-10-14),

10. 8771685 - Anti-BV8 antibodies and uses thereof (2014-07-08),

11. 8604185 - Inhibitors of angiopoietin-like 4 protein, combinations, and their use (2013-12-10),

12. 8557238 - EG-VEGF nucleic acids and polypeptides and methods of use (2013-10-15),

13. 8541376 - Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 (2013-09-24),

14. 8287873 - Vascular endothelial cell growth factor antagonists and uses thereof (2012-10-16),

15. 8273353 - Inhibitors of vascular endothelial growth factor activity (2012-09-25),

Title: The Innovative Journey of Inventor Napoleone Ferrara

Introduction: Inventor Napoleone Ferrara, a distinguished figure in the field of biotechnology and medical research, has made significant contributions to the world through his groundbreaking inventions and discoveries. Born in San Francisco, CA (US), Ferrara's work has revolutionized the way we approach healthcare and disease treatment.

Latest Patents: Ferrara holds several patents in the field of biotechnology and medical research, including patents related to novel drug delivery systems, innovative treatment methods for various diseases, and cutting-edge medical devices aimed at improving patient outcomes.

Career Highlights: With a career spanning several decades, Ferrara has held key positions in renowned research institutions and biotechnology companies. He is known for his pivotal role in the development of anti-angiogenic therapy, which has transformed the treatment of cancer and other diseases. Ferrara's research has led to the development of life-saving drugs that have had a profound impact on patient care worldwide.

Collaborations: Throughout his career, Ferrara has collaborated with leading scientists, researchers, and healthcare professionals to further the boundaries of medical innovation. His collaborative efforts have resulted in groundbreaking discoveries and advancements in the field of biotechnology, cementing his reputation as a visionary inventor.

Conclusion: Inventor Napoleone Ferrara's relentless pursuit of innovation and his unwavering commitment to improving healthcare have solidified his position as a trailblazer in the field of biotechnology. His groundbreaking inventions and contributions continue

Profile summary based on public USPTO records.